Pfizer COVID-19 Vaccine FDA approved for Patients 12 years and older

The two primary vaccines to prevent COVID-19 given in the US are the mra vaccines developed/marketed by Moderna and Pfizer.   The rapid immunization rates leveraging these vaccines has been a critical component of fighting the COVID-19 Pandemic.  This week, the Pfizer COVID-19 vaccine was approved by the FDA for use in children 12 years…

Vaccine Management

Preparing Pediatric Practices to be Ready for the COVID-19 Vaccines

Early Monday morning, November 9th, Pfizer announced some positive results regarding their COVID-19 Vaccine they are developing with BioNTech.  This vaccine candidate is a two-dose series.    The phase III clinical trials involved over 40,000 patients.    There is some data in the press release that based on exposing patients who received the vaccine to…